Olaplex (NASDAQ:OLPX) Price Target Raised to $2.06

Olaplex (NASDAQ:OLPX) had its price target increased by Telsey Advisory Group from $2.00 to $2.06 in a research report sent to investors on Friday,Benzinga reports. Telsey Advisory Group currently has a market perform rating on the stock.

Several other equities research analysts have also recently commented on OLPX. Jefferies Financial Group reissued a “buy” rating on shares of Olaplex in a research note on Wednesday, March 4th. Weiss Ratings reiterated a “sell (d)” rating on shares of Olaplex in a research report on Thursday, January 22nd. Northland Securities cut Olaplex from a “strong-buy” rating to a “hold” rating in a report on Thursday. Morgan Stanley set a $1.40 target price on shares of Olaplex in a research report on Tuesday, March 10th. Finally, Evercore set a $2.50 target price on shares of Olaplex in a research note on Friday, March 6th. One analyst has rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $1.89.

Olaplex Price Performance

Shares of NASDAQ:OLPX opened at $2.02 on Friday. The company has a quick ratio of 4.00, a current ratio of 4.58 and a debt-to-equity ratio of 0.40. The firm has a market cap of $1.35 billion, a P/E ratio of -202.00 and a beta of 2.24. Olaplex has a 12 month low of $0.99 and a 12 month high of $2.02. The company’s 50-day moving average price is $1.51 and its two-hundred day moving average price is $1.35.

Olaplex (NASDAQ:OLPX) last released its quarterly earnings results on Thursday, March 5th. The company reported $0.01 EPS for the quarter, meeting the consensus estimate of $0.01. The business had revenue of $105.12 million for the quarter, compared to analysts’ expectations of $104.21 million. Olaplex had a negative net margin of 2.19% and a positive return on equity of 1.07%. Olaplex’s revenue was up 4.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.01 earnings per share. As a group, research analysts forecast that Olaplex will post 0.1 EPS for the current fiscal year.

Insider Buying and Selling

In related news, General Counsel John C. Duffy sold 34,962 shares of the company’s stock in a transaction dated Thursday, March 12th. The stock was sold at an average price of $1.26, for a total value of $44,052.12. Following the completion of the sale, the general counsel owned 982,855 shares in the company, valued at approximately $1,238,397.30. This represents a 3.43% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CFO Catherine Dunleavy sold 93,809 shares of the stock in a transaction dated Thursday, March 12th. The shares were sold at an average price of $1.26, for a total value of $118,199.34. Following the completion of the transaction, the chief financial officer directly owned 3,026,885 shares in the company, valued at $3,813,875.10. The trade was a 3.01% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 215,442 shares of company stock valued at $271,457 over the last three months. Company insiders own 4.20% of the company’s stock.

Institutional Trading of Olaplex

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Archon Capital Management LLC boosted its stake in Olaplex by 40.4% during the 4th quarter. Archon Capital Management LLC now owns 4,466,876 shares of the company’s stock worth $5,986,000 after acquiring an additional 1,284,557 shares during the last quarter. Geode Capital Management LLC grew its holdings in Olaplex by 2.8% during the fourth quarter. Geode Capital Management LLC now owns 3,865,034 shares of the company’s stock valued at $5,180,000 after purchasing an additional 106,048 shares during the period. Portolan Capital Management LLC increased its stake in Olaplex by 132.6% in the third quarter. Portolan Capital Management LLC now owns 3,635,124 shares of the company’s stock valued at $4,762,000 after purchasing an additional 2,072,383 shares in the last quarter. Ninety One UK Ltd increased its stake in Olaplex by 4.1% in the fourth quarter. Ninety One UK Ltd now owns 3,525,027 shares of the company’s stock valued at $4,724,000 after purchasing an additional 139,109 shares in the last quarter. Finally, State Street Corp raised its holdings in Olaplex by 3.5% in the fourth quarter. State Street Corp now owns 3,059,988 shares of the company’s stock worth $4,100,000 after purchasing an additional 103,875 shares during the period. 87.37% of the stock is owned by institutional investors.

Trending Headlines about Olaplex

Here are the key news stories impacting Olaplex this week:

• Positive Sentiment: Henkel agreed to acquire Olaplex for $2.06 per share (≈$1.4 billion), a ~55% premium to the pre-announcement close; the deal is being pitched as enabling greater investment and distribution for the brand. OLAPLEX to be Acquired by Henkel for $1.4 Billion
• Positive Sentiment: Heavy bullish activity and strong market reaction: premarket headlines and commentary noted a large surge after the announcement, and unusual options activity (large buy of calls) signaled speculative and takeover-arbitrage positioning. Wall Street Breakfast Podcast: Henkel Adds Shine With Olaplex
• Neutral Sentiment: Small analyst adjustments: Telsey Advisory Group raised its price target marginally to $2.06 and kept a “market perform” rating — a modest validation of the deal price but not a strong new bullish signal. Benzinga
• Negative Sentiment: Multiple shareholder-law firms have launched investigations into whether Olaplex shareholders received a fair price or whether there were breaches of fiduciary duty in connection with the sale — this raises litigation risk and could complicate closing/timing. M&A Class Action Firm Announces Investigation Ademi Firm Investigates Fair Price
• Negative Sentiment: Critical analysis and a downgrade: commentary pieces flagged negative implications of the sale for certain stakeholders, and Northland downgraded the stock from “strong-buy” to “hold” — both could reduce enthusiasm among some investors. Henkel Buys Olaplex – Implications Are Negative Zacks (Northland downgrade)

About Olaplex

Olaplex, Inc (NASDAQ: OLPX) is a specialty haircare company known for its patented bond-building technology designed to repair and strengthen hair from within. The company’s core offerings encompass a range of professional salon treatments and at-home maintenance products that target chemical damage, breakage and split ends. Olaplex formulations are built around a proprietary active ingredient that works at the molecular level to rebuild disulfide bonds broken during bleaching, coloring and heat styling processes.

Founded in 2014 and headquartered in Irvine, California, Olaplex initially gained traction among high-end salons before expanding into broader retail channels.